Shanghai ZJ Bio-Tech Co. Ltd. A

SHG:688317 China Medical Devices
Market Cap
$520.65 Million
CN¥3.82 Billion CNY
Market Cap Rank
#13299 Global
#3391 in China
Share Price
CN¥19.88
Change (1 day)
-0.20%
52-Week Range
CN¥15.26 - CN¥28.98
All Time High
CN¥80.15
About

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. It offers nucleic acid and real-time PCR kits, as well as consumables. The company was founded in 2005 and is based in Shanghai, China.

Shanghai ZJ Bio-Tech Co. Ltd. A - Asset Resilience Ratio

Latest as of September 2025: 9.52%

Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has an Asset Resilience Ratio of 9.52% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
CN¥354.30 Million
Cash + Short-term Investments
Total Assets
CN¥3.72 Billion
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2014–2014)

This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Shanghai ZJ Bio-Tech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥354.30 Million 9.52%
Total Liquid Assets CN¥354.30 Million 9.52%

Asset Resilience Insights

  • Limited Liquidity: Shanghai ZJ Bio-Tech Co. Ltd. A maintains only 9.52% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shanghai ZJ Bio-Tech Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai ZJ Bio-Tech Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Shanghai ZJ Bio-Tech Co. Ltd. A (2014–2014)

The table below shows the annual Asset Resilience Ratio data for Shanghai ZJ Bio-Tech Co. Ltd. A.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2014-12-31 2.64% CN¥5.28 Million CN¥199.63 Million --
pp = percentage points